Article
Reflex testing of resected stage I through III lung adenocarcinomas for EGFR and KRAS mutation: report on initial experience and clinical utility at a single center.
The Journal of thoracic and cardiovascular surgery - 1 Feb 2011
D'Angelo Sandra P, Park Bernard, Azzoli Christopher G, Kris Mark G, Rusch Valerie, Ladanyi Marc, Zakowski Maureen F
Abstract excerpt
OBJECTIVE: The genes KRAS and EGFR have emerged as potential targets for therapy in lung adenocarcinoma; mutations in these genes can be found in almost half of patients. In anticipation of the clinical importance of molecularly defined adenocarcinoma subgroups for the treatment of patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
